Optimal antiplatelet therapy in patients at high bleeding risk undergoing complex percutaneous coronary intervention

被引：7
|
作者：
Ortega-Paz, Luis [1 ]
Angiolillo, Dominick J. [1 ]
机构：
[1] Univ Florida, Div Cardiol, Coll Med, ACC Bldg 5th Floor,655 West 8th St, Jacksonville, FL 32209 USA
来源：
EUROPEAN HEART JOURNAL | 2022年 / 43卷 / 33期
关键词：
TICAGRELOR;
D O I：
10.1093/eurheartj/ehac369
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This editorial refers to 'Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis', by M. Valgimigli et al., https://doi.org/10.1093/eurheartj/ehac284.
引用
收藏
页码：3115 / 3117
页数：3
相关论文
共 50 条
  • [1] Antiplatelet Therapy in Percutaneous Coronary Intervention Patients with Concurrent High Ischemic and Bleeding Risk
    Mauro, Maria Sara
    Capodanno, Davide
    THROMBOSIS AND HAEMOSTASIS, 2025,
  • [2] Optimal Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention: A Focused Review on High Bleeding Risk
    Matsuura, Yunosuke
    Moribayashi, Kohei
    Kaikita, Koichi
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2022, 29 (10) : 1409 - 1420
  • [3] Perceived or Calculated Bleeding Risk and Their Relation With Dual Antiplatelet Therapy Duration in Patients Undergoing Percutaneous Coronary Intervention
    Ferlini, Marco
    Rossini, Roberta
    Musumeci, Giuseppe
    Grieco, Niccolo
    Demarchi, Andrea
    Trabattoni, Daniela
    Parenti, Dennis Zavalloni
    Pierini, Simona
    Castiglioni, Battistina
    Somaschini, Alberto
    Cornara, Stefano
    Lettieri, Corrado
    Visconti, Luigi Oltrona
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (06)
  • [4] Frequency of high bleeding risk in patients undergoing percutaneous coronary intervention
    Mahmood, Muhammad Muzaffar
    Eajaz, Farwa
    Hussain, Aasif
    Zahid, Arva
    Saeed, Kiran
    Rehman, Junaid
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2021, 71 (09) : 2186 - 2191
  • [5] Bleeding versus ischemic risk during dual antiplatelet therapy on patients with acute coronary syndromes undergoing percutaneous coronary intervention
    Nau, Gerardo
    Lalor, Nicolas
    Pedernera, Gustavo
    Daquarti, Gustavo
    Spaletra, Pablo
    Candiello, Alfonsina
    Padilla, Lucio
    Trivi, Marcelo
    Cura, Fernando
    REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2016, 45 (02): : 67 - 72
  • [6] Antiplatelet Therapy in Patients Undergoing Elective Percutaneous Coronary Intervention
    Mohammad Alkhalil
    Vladimír Džavík
    Deepak L. Bhatt
    Roxana Mehran
    Shamir R. Mehta
    Current Cardiology Reports, 2022, 24 : 277 - 293
  • [7] Contemporary antiplatelet therapy in patients undergoing percutaneous coronary intervention
    Bhatty, Shaun
    Ali, Asghar
    Shetty, Ranjith
    Sumption, Kevin F.
    Cowley, Michael J.
    Jovin, Ion S.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2014, 12 (04) : 463 - 474
  • [8] Antiplatelet Therapy in Patients Undergoing Elective Percutaneous Coronary Intervention
    Alkhalil, Mohammad
    Dzavik, Vladimir
    Bhatt, Deepak L.
    Mehran, Roxana
    Mehta, Shamir R.
    CURRENT CARDIOLOGY REPORTS, 2022, 24 (03) : 277 - 293
  • [9] Short dual antiplatelet therapy in patients with high bleeding risk undergoing percutaneous coronary intervention: a systematic review and meta-analysis
    Zhang, Junyan
    Chen, Zhongxiu
    Li, Chen
    Wang, Duolao
    He, Siyu
    Luo, Chaoyu
    Luo, Fangbo
    He, Yong
    CORONARY ARTERY DISEASE, 2022, 33 (07) : 580 - 589
  • [10] Relevance of High Bleeding Risk and Postdischarge Bleeding in Patients Undergoing Percutaneous Coronary Intervention
    Ingraham, Brenden S.
    Valgimigli, Marco
    Angiolillo, Dominick J.
    Capodanno, Davide
    Rao, Sunil V.
    Urban, Philip
    Singh, Mandeep
    MAYO CLINIC PROCEEDINGS, 2025, 100 (02) : 304 - 331
12345